Luteolin-Treated 4T1 Cell-Derived Exosomes as Novel Antiproliferative Agents In Vitro and In Vivo.

Heidari P, Hosseini R, Nasihatgar N

Open source

DOI
10.18502/ajmb.v18i2.21499
Published
2026 Apr-Jun
Container
Avicenna journal of medical biotechnology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.18502/ajmb.v18i2.21499,
  title = {Luteolin-Treated 4T1 Cell-Derived Exosomes as Novel Antiproliferative Agents In Vitro and In Vivo.},
  author = {Heidari P and Hosseini R and Nasihatgar N},
  year = {2026},
  journal = {Avicenna journal of medical biotechnology},
  doi = {10.18502/ajmb.v18i2.21499},
  url = {https://doi.org/10.18502/ajmb.v18i2.21499}
}

RIS

TY  - JOUR
TI  - Luteolin-Treated 4T1 Cell-Derived Exosomes as Novel Antiproliferative Agents In Vitro and In Vivo.
AU  - Heidari P
AU  - Hosseini R
AU  - Nasihatgar N
PY  - 2026
JO  - Avicenna journal of medical biotechnology
DO  - 10.18502/ajmb.v18i2.21499
UR  - https://doi.org/10.18502/ajmb.v18i2.21499
ER  - 

APA

P, H., R, H., & N, N. (2026). Luteolin-Treated 4T1 Cell-Derived Exosomes as Novel Antiproliferative Agents In Vitro and In Vivo.. Avicenna journal of medical biotechnology. https://doi.org/10.18502/ajmb.v18i2.21499

Source records